As a nonprofit organization, we rely on financial support from readers like you
Cervone DT, Hucik B, Lovell AJ, Dyck DJ
The button felt like a trick
Our challenge now is effective strategies for implementation to really deliver on the promise of improving clinical outcomes for people with type 2 diabetes and CKD. Other speakers during the symposium included: Peter Rossing, MD, DMSc, Steno Diabetes Center Copenhagen, Denmark, who discussed the FLOW trial rationale
NICE recommends that people at higher risk of stomach problems should take a PPI (a stomach acid-reducing medication) alongside regular NSAID use
Diabetic ketoacidosis is a serious medical emergency characterised by very high ketone levels, severe hyperglycaemia, and metabolic acidosis requiring immediate treatment